Significant Reduction in Alzheimer’s Risk for Users of Semaglutide and SGLT2 Drugs
Recent medical research reveals that diabetes medications Ozempic and Jardiance may help reduce the risk of Alzheimer's disease, with a study showing GLP-1RAs lowering risk by 41% and SGLT2 inhibitors by 33% in patients with type 2 diabetes.